SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 186 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $24,612,000 | -18.5% | 206,490 | -25.4% | 0.02% | -29.2% |
| Q4 2018 | $30,188,000 | -66.8% | 276,624 | -50.9% | 0.02% | -20.0% |
| Q3 2018 | $91,056,000 | +231.0% | 563,780 | +170.9% | 0.03% | +66.7% |
| Q2 2018 | $27,506,000 | +83.7% | 208,098 | +2.9% | 0.02% | +80.0% |
| Q1 2018 | $14,976,000 | +39.4% | 202,136 | +4.7% | 0.01% | +42.9% |
| Q4 2017 | $10,744,000 | +17.8% | 193,096 | -4.0% | 0.01% | +16.7% |
| Q3 2017 | $9,122,000 | +62.9% | 201,092 | +21.1% | 0.01% | +50.0% |
| Q2 2017 | $5,599,000 | -5.4% | 166,089 | -17.0% | 0.00% | 0.0% |
| Q1 2017 | $5,920,000 | +1.2% | 200,002 | -6.2% | 0.00% | 0.0% |
| Q4 2016 | $5,849,000 | -62.0% | 213,246 | -14.9% | 0.00% | -60.0% |
| Q3 2016 | $15,381,000 | +211.5% | 250,460 | -3.3% | 0.01% | +150.0% |
| Q2 2016 | $4,937,000 | +16.7% | 258,882 | +19.5% | 0.00% | +33.3% |
| Q1 2016 | $4,230,000 | -46.6% | 216,707 | +5.5% | 0.00% | -50.0% |
| Q4 2015 | $7,923,000 | +24.7% | 205,373 | +3.8% | 0.01% | +20.0% |
| Q3 2015 | $6,352,000 | +5.6% | 197,833 | +0.1% | 0.01% | +25.0% |
| Q2 2015 | $6,013,000 | +70.7% | 197,608 | -25.5% | 0.00% | +100.0% |
| Q1 2015 | $3,522,000 | -8.0% | 265,219 | +0.2% | 0.00% | -33.3% |
| Q4 2014 | $3,829,000 | -33.2% | 264,585 | -2.7% | 0.00% | -25.0% |
| Q3 2014 | $5,735,000 | -30.1% | 271,815 | -1.4% | 0.00% | -33.3% |
| Q2 2014 | $8,210,000 | +27.3% | 275,597 | +2.7% | 0.01% | +20.0% |
| Q1 2014 | $6,447,000 | +51.6% | 268,281 | +28.5% | 0.01% | +66.7% |
| Q4 2013 | $4,252,000 | -41.1% | 208,742 | +36.5% | 0.00% | -50.0% |
| Q3 2013 | $7,222,000 | +47.7% | 152,903 | +19.0% | 0.01% | +50.0% |
| Q2 2013 | $4,890,000 | – | 128,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |